These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17922621)

  • 1. Peroxisome proliferator-activated receptor-gamma ligands as investigational modulators of angiogenesis.
    Giaginis C; Margeli A; Theocharis S
    Expert Opin Investig Drugs; 2007 Oct; 16(10):1561-72. PubMed ID: 17922621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator activated receptor-gamma (PPAR-gamma) ligands and angiogenesis.
    Margeli A; Kouraklis G; Theocharis S
    Angiogenesis; 2003; 6(3):165-9. PubMed ID: 15041792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands as potential therapeutic agents to treat arthritis.
    Giaginis C; Giagini A; Theocharis S
    Pharmacol Res; 2009 Sep; 60(3):160-9. PubMed ID: 19646655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma ligands as bone turnover modulators.
    Giaginis C; Tsantili-Kakoulidou A; Theocharis S
    Expert Opin Investig Drugs; 2007 Feb; 16(2):195-207. PubMed ID: 17243939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: novel pharmacological agents in the treatment of ischemia reperfusion injury.
    Giaginis C; Tsourouflis G; Theocharis S
    Curr Mol Med; 2008 Sep; 8(6):562-79. PubMed ID: 18781963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARgamma as a therapeutic target for tumor angiogenesis and metastasis.
    Panigrahy D; Huang S; Kieran MW; Kaipainen A
    Cancer Biol Ther; 2005 Jul; 4(7):687-93. PubMed ID: 16082179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer.
    Giaginis C; Tsantili-Kakoulidou A; Theocharis S
    PPAR Res; 2008; 2008():431763. PubMed ID: 18464916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peroxisome proliferator activated receptor ligands and angiogenesis].
    Sato M
    Nihon Rinsho; 2005 Apr; 63(4):603-8. PubMed ID: 15828227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.
    Abdelrahman M; Sivarajah A; Thiemermann C
    Cardiovasc Res; 2005 Mar; 65(4):772-81. PubMed ID: 15721857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.
    Nenicu A; Körbel C; Gu Y; Menger MD; Laschke MW
    Hum Reprod; 2014 May; 29(5):1011-24. PubMed ID: 24578472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptors and angiogenesis.
    Biscetti F; Straface G; Pitocco D; Zaccardi F; Ghirlanda G; Flex A
    Nutr Metab Cardiovasc Dis; 2009 Dec; 19(11):751-9. PubMed ID: 19628379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of 15-deoxy-delta(12,14)-prostaglandin J(2), an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis.
    Kim EH; Surh YJ
    Biochem Pharmacol; 2008 Dec; 76(11):1544-53. PubMed ID: 18771658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-gamma ligands for the treatment of breast cancer.
    Fenner MH; Elstner E
    Expert Opin Investig Drugs; 2005 Jun; 14(6):557-68. PubMed ID: 16004588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510.
    Huang H; Campbell SC; Bedford DF; Nelius T; Veliceasa D; Shroff EH; Henkin J; Schneider A; Bouck N; Volpert OV
    Mol Cancer Res; 2004 Oct; 2(10):541-50. PubMed ID: 15498928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on Atherosclerosis.
    Ivanova EA; Myasoedova VA; Melnichenko AA; Orekhov AN
    Curr Pharm Des; 2017; 23(7):1119-1124. PubMed ID: 27855608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between peroxisome proliferator activator-receptor (PPAR) and urological cancer].
    Yoshimura R; Nakatani T
    Nihon Rinsho; 2005 Apr; 63(4):672-8. PubMed ID: 15828236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors modulate proliferation and angiogenesis in human endometrial carcinoma.
    Nickkho-Amiry M; McVey R; Holland C
    Mol Cancer Res; 2012 Mar; 10(3):441-53. PubMed ID: 22205725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists.
    Libby P; Plutzky J
    Am J Cardiol; 2007 Feb; 99(4A):27B-40B. PubMed ID: 17307056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor (PPAR) gamma in cardiovascular disorders and cardiovascular surgery.
    Ivanova EA; Parolari A; Myasoedova V; Melnichenko AA; Bobryshev YV; Orekhov AN
    J Cardiol; 2015 Oct; 66(4):271-8. PubMed ID: 26072262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) as a Target for Concurrent Management of Diabetes and Obesity-Related Cancer.
    Wang Q; Imam MU; Yida Z; Wang F
    Curr Pharm Des; 2017; 23(25):3677-3688. PubMed ID: 28677503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.